IL6 and cancer: We recently highlighted an IL-6-related pathway that may connect inflammation to cancer: we found that IL-6 down-regulated the expression and activity of p53 in transformed and untransformed human cell lines, and that p53 down-regulation led to the acquisition of cellular phenotypic changes which are characteristic of epithelial-mesenchymal transition (EMT) [22].